Efficacy andtolerability Study of Amrutanjan advanced joint muscle plus spray for pain relief
- Conditions
- Health Condition 1: M259- Joint disorder, unspecified
- Registration Number
- CTRI/2021/09/036890
- Lead Sponsor
- Amrutanjan Health Care Limited Tamil Nadu India
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 48
1.Patients of either sex aged above 18 years.
2.Patients who are able to understand written and/or verbal instructions and are ready to comply with all study requirements with a willingness to participate and give written informed consent voluntarily.
3.Patients who had been diagnosed with acute and chronic localized musculoskeletal pain and joint pain disorders.
Patients presenting with any of the following will not be included in the trial.
1.Women of child bearing potential who are either unwilling or unable to use an acceptable method of birth control [such as oral contraceptives, other hormonal contraceptives (implants or injectable products, vaginal products, skin patches), or IUDs, barrier methods] to avoid pregnancy during the study period.
2.Subject with active skin lesions or other skin diseases.
3.Subject with history of uncontrolled diabetes (HbA1C of more than 9)
4.Known allergy to compounds of investigational product.
5.Fracture, Ligament tear, sports injury patient will be excluded
6.Subject undergoing physiotherapy session will be excluded.
7.Patients suffering from medical or psychiatric conditions that would increase the risk of adverse events or interfere with study assessments.
8.Participation in an investigational drug trial in the30 days prior to the screening visit.
9.Patients of vulnerable group (children, lactating mother, elderly >80 years, handicapped, seriously ill, mentally challenged).
10.History of drug or alcohol abuse during the last 6 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method